Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma

AIM: In patients with isocitrate dehydrogenase (IDH) mutated anaplastic glioma determine the dosimetric benefits of delivering radiation therapy using a PET guided integrated boost IMRT technique (ib-IMRT) compared with standard IMRT (s-IMRT) in reducing dose to normal brain. METHODS: Ten patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Back, M., LeMottee, M., Crasta, C., Bailey, D., Wheeler, H., Guo, L., Eade, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335728/
https://www.ncbi.nlm.nih.gov/pubmed/28253929
http://dx.doi.org/10.1186/s13014-017-0782-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335728/
https://www.ncbi.nlm.nih.gov/pubmed/28253929
http://dx.doi.org/10.1186/s13014-017-0782-3

Ejemplares similares